IL130954A0 - Neurturin receptor - Google Patents

Neurturin receptor

Info

Publication number
IL130954A0
IL130954A0 IL13095498A IL13095498A IL130954A0 IL 130954 A0 IL130954 A0 IL 130954A0 IL 13095498 A IL13095498 A IL 13095498A IL 13095498 A IL13095498 A IL 13095498A IL 130954 A0 IL130954 A0 IL 130954A0
Authority
IL
Israel
Prior art keywords
ntnr
alpha
antibodies
neurturin receptor
neurturin
Prior art date
Application number
IL13095498A
Other languages
English (en)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/802,805 external-priority patent/US6372453B1/en
Priority claimed from US08/957,063 external-priority patent/US6025157A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL130954A0 publication Critical patent/IL130954A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Psychology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL13095498A 1997-02-18 1998-12-17 Neurturin receptor IL130954A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/802,805 US6372453B1 (en) 1997-02-18 1997-02-18 Neurturin receptor
US87191397A 1997-06-09 1997-06-09
US08/957,063 US6025157A (en) 1997-02-18 1997-10-24 Neurturin receptor
PCT/US1998/003179 WO1998036072A1 (fr) 1997-02-18 1998-02-17 Recepteur de la neurturine

Publications (1)

Publication Number Publication Date
IL130954A0 true IL130954A0 (en) 2001-01-28

Family

ID=27419991

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13095498A IL130954A0 (en) 1997-02-18 1998-12-17 Neurturin receptor
IL130954A IL130954A (en) 1997-02-18 1999-07-15 HUMAN NEURTURIN RECEPTOR- a (NTNR a ) POLYPEPTIDES, ANTIBODIES TO NTNR a AND COMPOSITION COMPRISING THE SAME

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL130954A IL130954A (en) 1997-02-18 1999-07-15 HUMAN NEURTURIN RECEPTOR- a (NTNR a ) POLYPEPTIDES, ANTIBODIES TO NTNR a AND COMPOSITION COMPRISING THE SAME

Country Status (10)

Country Link
EP (1) EP1007666B1 (fr)
JP (1) JP4086324B2 (fr)
AT (1) ATE312915T1 (fr)
AU (1) AU730430B2 (fr)
CA (1) CA2281620C (fr)
DE (1) DE69832797T2 (fr)
DK (1) DK1007666T3 (fr)
ES (1) ES2258295T3 (fr)
IL (2) IL130954A0 (fr)
WO (1) WO1998036072A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696259B1 (en) 1995-11-13 2004-02-24 Licentia Ltd. Assays using glial cell line-derived neurotrophic factor receptors
US6677135B1 (en) 1996-05-08 2004-01-13 Biogen, Inc. Ret ligand (RetL) for stimulating neutral and renal growth
AU748639B2 (en) * 1997-04-17 2002-06-06 Washington University Receptors for TGF-beta-related neurotrophic factors
AU741208B2 (en) * 1997-05-22 2001-11-22 Urmas Arumae Glial cell line-derived neurotrophic factor receptors
WO1998054213A2 (fr) * 1997-05-30 1998-12-03 Amgen Inc. Recepteurs du facteur neurotrope
WO1999049039A2 (fr) * 1998-03-23 1999-09-30 Genentech, Inc. LE GFRα3 ET SES UTILISATIONS
EP1119772A1 (fr) * 1998-10-01 2001-08-01 Alexey Vladimirovich Titievsky Nouvelle voie de signalisation independante de ret pour gdnf
US6905817B1 (en) 1998-10-01 2005-06-14 Licestia Ltd. Ret-independent signaling pathway for GDNF
FI991197A0 (fi) * 1999-05-27 1999-05-27 Mart Saarma Neurotrooppiset tekijät lantionalueen ääreishermoston toimintahäiriön hoitamisessa
PL1694354T3 (pl) * 2003-11-27 2009-12-31 Develogen Ag Sposób zapobiegania i leczenia cukrzycy za pomocą neurturyny
CN104220461A (zh) 2011-12-29 2014-12-17 Atyr医药公司 天冬氨酰-tRNA合成酶-FC缀合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE335003T1 (de) * 1996-05-08 2006-08-15 Biogen Idec Inc Ret-ligand 3 (retl3), um neurales und renales wachstum zu stimulieren

Also Published As

Publication number Publication date
EP1007666B1 (fr) 2005-12-14
CA2281620C (fr) 2012-05-01
DE69832797T2 (de) 2006-08-17
EP1007666A1 (fr) 2000-06-14
JP4086324B2 (ja) 2008-05-14
IL130954A (en) 2008-11-26
AU730430B2 (en) 2001-03-08
WO1998036072A1 (fr) 1998-08-20
AU6175098A (en) 1998-09-08
DE69832797D1 (de) 2006-01-19
DK1007666T3 (da) 2006-05-08
CA2281620A1 (fr) 1998-08-20
JP2002511738A (ja) 2002-04-16
ES2258295T3 (es) 2006-08-16
ATE312915T1 (de) 2005-12-15

Similar Documents

Publication Publication Date Title
DK0888385T3 (da) GDNF receptor og anvendelser deraf
MX9709324A (es) Compuestos terapeuticos que comprenden anticuerpos anti receptores fc.
PT800519E (pt) Compostos moduladores de receptores de esteroides e metodos
MX9704640A (es) Compuesto moduladores de los receptores de los esteroides y metodos para su preparacion.
AU4622297A (en) Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr)
TW200607814A (en) Cell surface receptor isoforms and methods of identifying and using the same
AU4677699A (en) Methods for identifying novel multimeric agents that modulate receptors
WO2000070049A3 (fr) Molecules de signalisation extracellulaires
IL130954A0 (en) Neurturin receptor
EP1081492A4 (fr) Remplissage pour chromatographie ayant une nouvelle caracteristique et procede d'isolation d'une substance utilisant ledit remplissage
WO2002046228A3 (fr) Recepteur de la toxine du b. anthracis
ZA200006080B (en) Human BMP-7 promoter and method for exploring bone-related substance by using the same.
WO1995007934A3 (fr) Inhibiteurs de il8
YU41998A (sh) Tetrahidrobetakarbolinska jedinjenja
AU2001266975A1 (en) G-protein coupled receptors
WO2002039118A8 (fr) Procedes de criblage de mimetiques morphogenetiques osseux
AUPN646795A0 (en) Neuropeptide Y-Y5 receptor
WO1999057270A3 (fr) Molecules de recepteur humain
GB9818656D0 (en) Heating unit for vaporizing sample by heating
WO2004069859A3 (fr) Restauration des fonctions des recepteurs mutants de l'hormone de liberation de la gonadotrophine
WO2004070347A3 (fr) Depistage pour modulateurs du stockage des graisses
WO1999043807A3 (fr) Molecules liees aux canaux humains
IT231374Y1 (it) Sedile, particolarmente per pianisti
GB9704300D0 (en) Analysis for the presence of degenerative brain disease

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed